<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Polymorphisms in MDA-5 link protein function to clearance of hepatitis C virus</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-02-01">2016 February 01</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Franziska</forename><surname>Hoffmann</surname></persName>
							<email>franziska.hoffmann@med.uni-muenchen.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="department" key="dep2">Klinikum Großhadern</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Schmidt</surname></persName>
							<email>aschmidt@mpiib-berlin.mpg.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Meike</forename><surname>Dittmann Chevillotte</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">Laboratory of Virology and Infectious Disease</orgName>
								<orgName type="institution">The Rockefeller University</orgName>
								<address>
									<settlement>New York</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Wisskirchen</surname></persName>
							<email>chr.wisskirchen@gmail.com</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><forename type="middle">C</forename><surname>Hellmuth</surname></persName>
							<email>johannes.hellmuth@med.uni-muenchen.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simone</forename><surname>Willms</surname></persName>
							<email>simone.willms@googlemail.com</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rachel</forename><forename type="middle">H</forename><surname>Gilmore</surname></persName>
							<email>rachel.h.gilmore@gmail.com</email>
							<affiliation key="aff3">
								<orgName type="laboratory">Laboratory of Virology and Infectious Disease</orgName>
								<orgName type="institution">The Rockefeller University</orgName>
								<address>
									<settlement>New York</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jürgen</forename><surname>Glas</surname></persName>
							<email>jglas@ukaachen.de</email>
							<affiliation key="aff4">
								<orgName type="department">Department for Preventive Dentistry and Periodontology</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Human Genetics</orgName>
								<orgName type="institution">RWTH</orgName>
								<address>
									<settlement>Aachen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Folwaczny</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department for Preventive Dentistry and Periodontology</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Müller</surname></persName>
							<email>tobias.mueller@medizin.uni-leipzig.de</email>
							<affiliation key="aff6">
								<orgName type="department">Department of Gastroenterology and Hepatology</orgName>
								<orgName type="institution">Charité University Hospital</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Berg</surname></persName>
							<email>thomas.berg@medizin.uni-leipzig.de</email>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Gastroenterology and Rheumatology</orgName>
								<orgName type="department" key="dep2">Section Hepatology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Leipzig</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrich</forename><surname>Spengler</surname></persName>
							<email>ulrich.spengler@ukb.uni-bonn.de</email>
							<affiliation key="aff8">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of Bonn</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karen</forename><surname>Fitzmaurice</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Trinity Centre for Health Sciences</orgName>
								<orgName type="institution" key="instit2">St. James&apos; Hospital</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dermot</forename><surname>Kelleher</surname></persName>
							<email>kellehdp@tcd.ie</email>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Trinity Centre for Health Sciences</orgName>
								<orgName type="institution" key="instit2">St. James&apos; Hospital</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicole</forename><surname>Reisch</surname></persName>
							<email>nicole.reisch@med.uni-muenchen.de</email>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Section Gastroenterology and Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charles</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
							<email>ricec@mail.rockefeller.edu</email>
							<affiliation key="aff3">
								<orgName type="laboratory">Laboratory of Virology and Infectious Disease</orgName>
								<orgName type="institution">The Rockefeller University</orgName>
								<address>
									<settlement>New York</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><surname>Endres</surname></persName>
							<email>endres@lmu.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Simon</forename><surname>Rothenfusser</surname></persName>
							<email>simon.rothenfusser@med.uni-muenchen.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center of Integrated Protein Research Munich (CIPS-M) and Division of Clinical Pharmacology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Section Gastroenterology and Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Division of Clinical Pharmacology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik IV</orgName>
								<orgName type="institution">University of Munich</orgName>
								<address>
									<addrLine>Ziemssenstr. 1</addrLine>
									<postCode>D-80336</postCode>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Polymorphisms in MDA-5 link protein function to clearance of hepatitis C virus</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-02-01">2016 February 01</date>
						</imprint>
					</monogr>
					<idno type="MD5">FE44217600E4EAA7D0D5EA1BF7B04811</idno>
					<idno type="DOI">10.1002/hep.27344</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Hepatitis C virus infection</term>
					<term>liver</term>
					<term>RIG-I-like helicase pathway</term>
					<term>single nucleotide polymorphism</term>
					<term>genetic association</term>
					<term>IFIH1</term>
					<term>diabetes type I</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Among patients newly infected with hepatitis C virus (HCV), only 20-30 % clear the infection spontaneously.</s><s>In the remaining 70 %, the infection persists causing chronic liver inflammation and disease.</s><s>It is well established that polymorphisms in host genes, especially in components of the innate immune response, contribute to the phenomenon of spontaneous HCV clearance.</s><s>RIG-Ilike helicases such as MDA-5 are cytoplasmic sensors of viral RNA that are critical for triggering innate immune responses after infection with RNA viruses.</s><s>We analysed 14 non-synonymous single-nucleotide polymorphisms in RIG-I-like helicase-pathway-genes comparing European patients that spontaneously cleared HCV (n = 285) or had persistent infection (n = 509).</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>With 170 million people affected worldwide chronic hepatitis C virus (HCV) infection is a major public health problem causing cirrhosis, liver failure and hepatocellular carcinoma.</s><s>The heterogeneity in HCV clearance within infected individuals -spontaneously as well as in response to treatment with interferon-α and ribavirin -is well documented but poorly understood.</s><s>Recent genome wide association studies have demonstrated the particularly strong contribution of genetic polymorphisms in innate immunity-related genes of the host to HCV clearance, complementing other known factors such as age at infection, gender, ethnicity and viral factors <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b1">2)</ref>.</s><s>Among reported genes for cytokines, chemokines, chemokine receptors, MHC molecules and NK cell receptors, single nucleotide polymorphisms (SNPs) in the locus of the type III interferon IL-28B have shown the most consistent and strongest association with spontaneous clearance of HCV and response to therapy with pegylated interferon-α and ribavirin <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b6">(6)</ref>.</s></p><p><s>Interferons (IFNs) type I and type III are major innate immune cytokines produced by cells upon viral infection.</s><s>They trigger transcriptional upregulation of host genes to build a strong line of antiviral defense.</s><s>In fact, many interferon-stimulated gene products have been identified to contribute to HCV clearance <ref type="bibr" target="#b7">(7,</ref><ref type="bibr" target="#b8">8)</ref>.</s><s>IFNs themselves are produced upon wellstudied signaling events, initiated by pattern recognition receptors (PRRs) detecting intracellular pathogens <ref type="bibr" target="#b9">(9)</ref>.</s><s>The RIG-I-like helicases (RLHs) retinoic acid-inducible gene-I (RIG-I), melanoma differentiation-associated gene 5 (MDA-5) and laboratory of genetics and physiology gene 2 (Lgp2) form an important family of cytoplasmic PRRs triggering the induction of IFNs upon viral infection.</s><s>RLHs detect the presence of viruses through the recognition of distinct molecular patterns in viral RNA species present in the cytoplasm of infected cells.</s><s>The molecular pattern detected by RIG-I consists of RNA containing a 5′triphosphate moiety in direct proximity to a double-stranded RNA stretch.</s><s>The pattern detected by MDA-5 is less well defined and requires long double stranded RNA <ref type="bibr" target="#b10">(10)</ref><ref type="bibr" target="#b11">(11)</ref><ref type="bibr" target="#b12">(12)</ref>.</s><s>Upon binding of their RNA ligands, RIG-I and MDA-5 induce a signaling cascade that involves the mitochondrial antiviral signaling protein (MAVS), the signaling adaptor protein for both receptors.</s><s>This leads ultimately to the activation of transcription factors and the transcriptional induction of IFNs and interferon-stimulated genes <ref type="bibr" target="#b13">(13,</ref><ref type="bibr" target="#b14">14)</ref>.</s><s>RIG-I and MDA-5 are activated through distinct but partially overlapping groups of viruses.</s></p><p><s>Based on cell culture models, several studies suggested that the RLH pathway, with an emphasis on RIG-I and MAVS, is critically involved in the recognition of HCV and a major target of immune evasion strategies of HCV <ref type="bibr" target="#b15">(15)</ref><ref type="bibr" target="#b16">(16)</ref><ref type="bibr" target="#b17">(17)</ref><ref type="bibr" target="#b18">(18)</ref>.</s></p><p><s>These findings led us to examine the effect of genetic polymorphisms in the core RLH pathway genes on HCV infection outcome.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PATIENTS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study participants</head><p><s>Informed consent was obtained from all patients that participated in the study.</s><s>The study protocol conforms to relevant ethical guidelines as reflected in approval by the ethics committees of the participating universities and hospitals.</s><s>The study population (n = 1316) was comprised of two cohorts of patients and a group of control individuals, all of Caucasian origin.</s><s>The first cohort consisted of 199 patients with chronic hepatitis C (CH) and 76 individuals with spontaneously resolved hepatitis C infection (SRH).</s><s>The second cohort consisted of 310 patients with chronic hepatitis C and 209 individuals with spontaneously resolved hepatitis C infection.</s><s>The control group (C) consisted of 520 healthy, unrelated individuals.</s><s>Members of the first cohort were haemophilic patients recruited from the University Hospital Bonn, Irish patients infected with contaminated anti-D immune globulin <ref type="bibr" target="#b19">(19)</ref> and patients recruited by the German Kompetenznetz Hepatitis.</s><s>The second cohort was recruited from three different liver centers across Germany.</s><s>Healthy controls were obtained from the blood donor pool of the blood bank in Freiburg.</s><s>Chronic hepatitis C was defined as detectable anti-HCV antibodies and HCV RNA in the serum for a minimum of 6 months.</s><s>Individuals designated "spontaneously cleared" had anti-HCV antibodies and undetectable HCV RNA in the serum for a minimum of 100 days.</s><s>For the control group HCV negativity was defined by the absence of anti-HCV antibodies.</s><s>Demographic features of the patient and control groups are presented in table 1 and supplementary tables 1.1 and 1.2.</s><s>For the haplotype correlation analysis of SNP combinations at rs1990760 and rs3747517 in MDA-5 subjects were only included if their chromosomal haplotype could be unambiguously determined.</s><s>Subjects heterozygous at both gene loci were therefore excluded, since in these cases our genotyping method does not allow to unambiguously assign their alleles to one chromosome.</s><s>This however is essential for the interpretation that the haplotype codes for amino acids of the same protein.</s><s>From the combined cohorts, 344 subjects of the group chronically infected with HCV (68%), 173 subjects of the group that cleared HCV spontaneously (67%) and 364 of the healthy controls (70%) could be included.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotyping and statistical analysis of genetic data</head><p><s>Genotyping was done by PCR and melting curve analysis in a LightCycler® 480 instrument (Roche Diagnostics, Mannheim, Germany) using fluorescence resonance energy transfer (FRET) probes (TIB MOLBIOL, Berlin, Germany).</s><s>Data were evaluated using the SPSS 16.0 software (SPSS Inc.-IBM, Armonk, NY) and Fisher's exact test or Chi square test where appropriate.</s><s>Haploview software was used to generate linkage disequilibrium plots for the analysed genes.</s><s>See supplementary methods and tables for additional details.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell stimulation and measurement of cytokine production and gene expression</head><p><s>HEK 293 cells were transfected in 96-well plates with the indicated plasmids using lipofectamine 2000 (Invitrogen Life Technologies).</s><s>24 hours after transfection, cells were stimulated with poly I:C (polyinosine-polycytidylic acid) (Invivogen, San Diego, California) complexed with lipofectamine 2000.</s><s>IP-10 and IL-28B were measured in the culture supernatants by ELISA (DuoSet, R&amp;D Systems, Minneapolis, MN and USCN, Life Science Inc., Wuhan, China).</s><s>Gene expression was analysed by quantitative RT-PCR using genespecific primers and probes from the Roche universal probe library (Roche Diagnostics, Mannheim, Germany).</s><s>The relative abundance of target transcripts was normalized to the expression levels of HPRT in experiments with Huh-7.5 cells and to the neomycin phosphotransferase (npt) gene in overexpression experiments in HEK293 cells to egalize potential differences in transfection.</s><s>See supplementary methods and tables for additional details.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HCV replication assay</head><p><s>HCV replication assays were performed as described previously <ref type="bibr" target="#b17">(17)</ref>.</s><s>Briefly, Huh-7.5 cells were plated in 24-well plates and transduced with lentiviral pseudoparticles expressing MDA-5 variants or controls, respectively, and additionally RFP as marker for transduction.</s><s>At 72h post transduction, cells were infected with HCV Jc1 378-1-YPet (20) at a dose yielding approximately 30-50% infected (GFP + ) cells.</s><s>At 48 h post infection, supernatants were collected and cells were analysed by FACS.</s><s>Virus titers from the supernatant were determined by TCID 50 assay on Huh-7.5 cells, as previously described <ref type="bibr" target="#b21">(21)</ref>.</s><s>To determine statistical significance, one-way analysis of variance (ANOVA) was used, followed by Dunnett's multiple comparison test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>To determine the impact of pattern recognition receptor variants on HCV clearance, we analysed 14 non-synonymous SNPs from the NCBI SNP database in the genes coding for RIG-I, MDA-5, Lgp-2 or their adapter MAVS with an expected minor allele frequency &gt; 1%.</s><s>When we examined an initial European cohort we detected a significant difference in allele distributions between 76 individuals with spontaneously resolved HCV infection (SRH) and 199 patients with chronic HCV infection (CH) only for SNP rs3747517 in MDA-5.</s><s>No significant difference in allele distribution was seen for the other SNPs analysed in MDA-5, RIG-I, Lgp2 or MAVS (see table <ref type="table" target="#tab_1">1 and 2</ref>).</s><s>The frequency of the minor T allele of rs3747517 coding for histidine at AA 843 in MDA-5 was significantly higher in the group of patients that had spontaneously recovered from hepatitis C infection (39.2% SRH versus 27.9% CH, p = 0.01; OR 1.67 (95%-CI: 1.12 -2.48); see table <ref type="table" target="#tab_1">2</ref>).</s><s>This was consistent with a significant difference of the genotype distributions for rs3747517 (p = 0.03 see table <ref type="bibr">3.1)</ref>.</s><s>This result could be replicated in a second independently collected European cohort consisting of 209 individuals with spontaneously resolved HCV infection and 310 patients with chronic HCV (p = 0.02; table <ref type="table">3</ref>.1).</s><s>The ability to replicate the result in a second cohort strongly argues against a type I error due to multiple testing as the explanation for the differences in allele distribution.</s></p><p><s>Similar to previous studies that identified polymorphisms at the IL-28B locus as the strongest predictors for the outcome of an HCV infection <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b6">(6)</ref>, we also found a strong difference in the allele distribution in the IL-28B gene SNP rs12979860.</s><s>As predicted, in our first cohort the C allele was significantly more frequent in patients able to clear the hepatitis C virus spontaneously (77.6% SRH versus 58.2% CH, p = 2.5 × 10 −5 ; OR 2.4 (95%-CI: 1.62 -3.83); see table 2).</s><s>To ensure that our results for the polymorphism in MDA-5 are not due to a coincidental over-or underrepresentation of genotypes at the IL-28B locus we analysed allele frequencies at rs3747517 in our first cohort using the genotype at rs12979860 in IL-28B as a covariate.</s><s>However, histidine at position 843 in MDA-5 still correlated with spontaneous HCV clearance in people carrying the non-protective genotypes CT or TT at the IL-28B locus (36.5% SRH versus 25.2% CH, p = 0.046; OR 1.7).</s><s>This strongly suggests that the SNP-alleles in MDA-5 have an independent effect that is not explained by the distribution of IL-28B polymorphisms in our cohort.</s></p><p><s>Combined analysis of the two cohorts for MDA-5 rs3747517 provided further statistical support for an overrepresentation of the T allele at rs3747517 in the group able to clear HCV infection spontaneously (p = 7 × 10 −3 ).</s><s>In this combined analysis individuals with the homozygous genotype TT at rs3747517 were 1.99-fold (95% CI: 1.27 -3.13; p = 4 × 10 −3 ) more likely to clear hepatitis C infection than individuals either heterozygous or not carrying the T allele at all (see table <ref type="table">3</ref>.2).</s></p><p><s>When we estimated the extent of linkage disequilibrium (LD) between rs3747517 and the other SNPs in MDA-5 we found strong LD (D′ = 0.765; r 2 = 0.362) for the polymorphisms rs3747517 and rs1990760 in MDA-5.</s><s>Several studies have previously identified a T at MDA-5 rs1990760 leading to threonine at AA 946 as a risk allele for diabetes type I <ref type="bibr" target="#b22">(22,</ref><ref type="bibr" target="#b23">23)</ref>.</s><s>Even though the allele distribution for rs1990760 by itself was not significantly associated with the outcome of HCV infection in either cohort or the combined analysis of both cohorts (see supplementary table <ref type="table">4</ref>) the strong LD between the two SNPs prompted us to further examine whether combination of alleles at rs3747517 and rs1990760 might be associated with the outcome of a hepatitis C infection.</s></p><p><s>The analysis of the combined cohorts identified a haplotype in MDA-5 composed of the minor allele T at rs3747517 and the major allele T at rs1990760 coding for a variant with histidine at position 843 and threonine at position 946, in the further manuscript denoted H843/T946, which was found at reduced frequency in patients with chronic hepatitis C compared to uninfected controls and strongly associated with spontaneous clearance of HCV infection (see figure <ref type="figure">1A</ref> and supplementary table 5.1).</s><s>The frequency of the haplotype coding for H843/T946 was significantly higher in the group of patients that spontaneously recovered from hepatitis C infection (6.6 % SRH versus 0.29 % CH; p = 3.4 × 10 −10 ; see figure <ref type="figure">1B</ref> and supplementary table 5.2).</s><s>Genotype analysis showed that carriers of this haplotype had a 16-fold higher chance of resolving HCV infection (OR: 16.23 (95 % CI: 3.67 -71.87); p = 1.1 × 10 −6 ; figure <ref type="figure">1C</ref>).</s><s>Notably all homozygous carriers of this haplotype in our study had cleared the infection (Supporting table 5.2).</s><s>Having seen the strong influence of the haplotype coding for H843/T946, we reevaluated, if the effect we had seen previously by analysing the SNP coding for AA 843 separately, was in fact caused by the haplotype.</s><s>This was indeed the case: A multivariate analysis of allele frequencies using the genotypes coding for the amino acid at 946 as covariates found no significant effect (p = 0.58) for H843 in subjects negative for T946 while it stayed significant (p = 0.02) in subjects bearing at least one allele coding for T946 and was highly significant in subjects homozygous for T946 (p = 3.1 × 10 −9 ).</s></p><p><s>As the genetic association data indicated that a combination of specific amino acids at position 843 and 946 in MDA-5 might be relevant for the function of the protein and for the immune response against HCV, we performed functional assays to test this hypothesis.</s><s>Using site-directed mutagenesis we generated constructs of MDA-5 variants containing the four possible amino acid combinations at AAs 843 and 946 encoded by the SNPs at rs3747517 and rs1990760.</s><s>In addition two previously described <ref type="bibr" target="#b24">(24,</ref><ref type="bibr" target="#b25">25)</ref> naturally occurring, loss-of-function MDA-5 variants, I923V and E627stop, and IRF-1 were included as controls in some experiments.</s><s>Overexpression of these MDA-5 variants in HEK 293 cells and stimulation with polyinosinic-polycytidylic acid (poly I:C) -a mimic of double-stranded viral RNA and known ligand for MDA-5 -revealed that the H843/T946 variant exhibits enhanced baseline and ligand-induced signaling activity leading to the increased expression of interferon-induced genes (ISG).</s><s>Upon activation with poly I:C the H843/T946 variant induced higher gene expression of IFN-β, IP-10, ISG15 and ISG56 and the secretion of more IP-10 and IL-28B into the supernatant than R843/T946 -the most common (wild type) variant in the European population -or any other of the tested variants (see figure <ref type="figure" target="#fig_1">2</ref>).</s><s>It is important to note that overexpression of MDA-variants in HEK 293 cells induces a low, but significant, induction of IP-10, IFN-β, ISG15 and ISG56 even in the absence of an added exogenous ligand.</s><s>The H843/T946 variant showed the highest activity also in this baseline ISG-induction (see figure <ref type="figure" target="#fig_1">2</ref>).</s></p><p><s>These results encouraged us to examine the function of the MDA-5 variants on HCV replication in a previously established cell culture system of HCV infection <ref type="bibr" target="#b17">(17)</ref>.</s><s>Huh-7.5 cells, a RIG-I-defective derivative of Huh-7 human hepatoma cells, were transduced to express the MDA-5 variants and RFP, and subsequently challenged with HCV encoding Ypet as a reporter gene (figure <ref type="figure" target="#fig_2">3A</ref>).</s><s>Viral replication (Ypet-expression) within the RFPpositive population was quantified by FACS analysis (figure <ref type="figure" target="#fig_2">3B</ref>).</s><s>Transduction with an empty vector served as negative control and was set 100% (figure <ref type="figure" target="#fig_2">3C</ref>).</s><s>IRF-1, a potent inhibitor of HCV replication <ref type="bibr" target="#b17">(17)</ref>, served as positive control.</s><s>Efficient replication with HCV was seen in the presence of the two functionally inactive MDA-5 variants, I923V and E627stop (see figure <ref type="figure" target="#fig_2">3B</ref>).</s><s>All other MDA-5 variants suppressed HCV replication, albeit with different efficiencies.</s><s>H843/T946 was significantly more potent than R843/T946 -the most common variant in the European population -or any other tested variant, inhibiting HCV replication by 50%.</s><s>This potent inhibition by H843/T946 translated to a 100-fold reduction of extracellular HCV titers at 48 h post infection (figure <ref type="figure" target="#fig_2">3D</ref>).</s><s>The increased efficiency is not explained by higher expression of H843/T946, as shown by western blot analyses (see supplementary figure <ref type="figure">1</ref>).</s><s>We further determined whether the enhanced virus inhibition by H843/T946 correlated with enhanced ISG expression upon HCV infection.</s><s>Of note, no ISG stimulation by HCV could be detected without overexpression of a functionally active MDA-5 (figure <ref type="figure" target="#fig_2">3E</ref>).</s><s>For IP-10, ISG15 and ISG56, H843/T946 showed induction even in the absence of HCV, albeit not statistically significant.</s><s>Furthermore, and in concordance to our previous experiments in HEK 293 cells and poly I:C stimulation (figure <ref type="figure" target="#fig_1">2</ref>), we found H843/T946 to be most potent in inducing ISG expression upon infection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Our data present the first genetic evidence for a role of MDA-5 in the natural course of HCV infection.</s><s>Our findings strongly argue in favor of an HCV-protective haplotype which is present in ~ 5% of the European population and which encodes an MDA-5 variant with enhanced functional activity.</s></p><p><s>Studies implicating the RLH pathway in HCV recognition <ref type="bibr" target="#b15">(15,</ref><ref type="bibr" target="#b16">16,</ref><ref type="bibr" target="#b18">18,</ref><ref type="bibr" target="#b26">26)</ref> so far suggested RIG-I as the primary RLH immune sensor for HCV.</s><s>Interestingly, West Nile virus, an RNA virus also in the Flaviviridae family, is sensed by both RIG-I and MDA-5 <ref type="bibr" target="#b27">(27)</ref>.</s><s>Furthermore, detailed studies examining specificity and potency of antiviral proteins showed that overexpressed MDA-5 is as potent as RIG-I in inhibiting HCV-replication <ref type="bibr" target="#b17">(17)</ref>.</s><s>Knockdown of MDA-5 partially rescues HCV replication suppressed via IFN-α in the RIG-I negative Huh-7.5 cell line <ref type="bibr" target="#b28">(28)</ref> and leads to reduced ISG-induction in RIG-I competent HepG2 cells <ref type="bibr" target="#b29">(29)</ref>.</s><s>Overexpression of paramyxovirus V proteins that were shown to engage and inhibit MDA-5 but not RIG-I lead to increased HCV replication and spread in primary human fetal liver cells <ref type="bibr" target="#b30">(30,</ref><ref type="bibr" target="#b31">31)</ref>.</s><s>It is also important to note that the HCV NS3-4A serine protease has evolved to interfere with the RLH pathway at the level of MAVS, the adapter for both, RIG-I and MDA-5 <ref type="bibr" target="#b16">(16)</ref>.</s><s>In the present study we see that overexpression of a functionally active MDA-5 is a prerequisite for induction of ISGs upon HCV infection in RIG-I deficient Huh-7.5 cells (figure <ref type="figure" target="#fig_2">3E</ref>).</s><s>Together, these findings implicate MDA-5 as an important determinant in the outcome of HCV infection.</s></p><p><s>The molecular pattern sensed by MDA-5 is still incompletely understood but studies indicate that the viral ligands for MDA-5 consist of long, higher-order dsRNA or dsRNA replication intermediates <ref type="bibr" target="#b11">(11,</ref><ref type="bibr" target="#b33">(32)</ref><ref type="bibr" target="#b34">(33)</ref><ref type="bibr" target="#b35">(34)</ref>.</s><s>Cell culture studies have defined distinct molecular patterns in the genomic RNA of HCV that can be sensed by RIG-I and PKR (reviewed in <ref type="bibr" target="#b15">(15)</ref>).</s><s>While these studies showed, that in vitro transcribed HCV RNA itself does not require MDA-5 to induce type-I interferon, dsRNA replicative intermediates of HCV that accumulate at later times during the replication cycle carry the characteristics to be bona fide ligands for MDA-5.</s><s>Further studies however are required to define the exact nature of the RNA species activating MDA-5 during HCV infection.</s></p><p><s>An early study analysed the SNPs rs1990760 and rs3747517 of MDA-5 separately and used a plasmid-construct coding for arginine 843/alanine 946 as the "wild type" source to generate their MDA-5 variants via point mutations.</s><s>It thereby missed an effect of the haplotype coding for H843/T946 and disregarded a significant effect of theses SNPs on protein function <ref type="bibr" target="#b25">(25)</ref>.</s><s>Later studies therefore assumed that these SNPs influence expression rather than function <ref type="bibr" target="#b22">(22)</ref>.</s><s>However, a study comparing the expression levels for each allele separately in heterozygotes convincingly showed that rs1990760 does not influence MDA-5 promoter activity <ref type="bibr" target="#b36">(35)</ref>.</s><s>Our results show that overexpression of the H843/T946 MDA-5 variant leads to a significantly higher induction of the interferon-stimulated gene products.</s><s>In addition, compared to wild type MDA-5 the H843/T946 MDA-5 variant leads to significantly stronger inhibition of HCV replication in Huh-7.5 cells.</s><s>This suggests that protein activity itself, and not elevated expression, is the reason for improved clearance of HCV infection in these haplotypes.</s></p><p><s>Novel insight into the structure of ligand-bound CARD-less MDA-5 and of its homologue RIG-I (36-40) might explain our findings.</s><s>AA 843 is situated within one of the most striking structural features of the RLH family, the elbow-like pincer motif.</s><s>The pincer structure is proposed to open and close upon RNA binding thereby altering the orientation of the CTD to the helicase domains.</s><s>In addition, AA 843 is directly adjacent to residues forming the head surface of the putative contact interface between MDA-5 monomers within the recently described MDA-5 filaments that form along dsRNA <ref type="bibr" target="#b40">(39,</ref><ref type="bibr" target="#b42">41)</ref>.</s><s>AA 946 of MDA-5 is located at the center of a loop within the C-terminal domain that, in RIG-I, is directly in contact with its RNA ligand (supplementary figure <ref type="figure" target="#fig_1">2</ref>).</s><s>The depletion of the CTDloop in MDA-5 leads to reduced signaling capacity, even though the affinity to dsRNA ligands is not reduced <ref type="bibr" target="#b40">(39)</ref>.</s><s>The pincer motif and the CTD loop were described as two structures in RLHs that make large movements upon activation required to adjust the fitting of the receptors to their RNA-ligands.</s><s>It is feasible that the two changes in H843/T946 MDA-5 at position 843 and 946 synergistically increase sensing of the viral RNA and/or improve transduction of the signal to downstream signaling molecules, resulting in a more efficient innate immune response that ultimately clears HCV infection in patients.</s><s>However, MDA-5 with increased activity might come at a cost.</s><s>Indeed, several studies have identified T at rs1990760 in MDA-5 as a risk allele for type 1 diabetes noting LD with rs3747517 <ref type="bibr" target="#b22">(22,</ref><ref type="bibr" target="#b23">23)</ref>.</s><s>Furthermore, rare loss-of-function variants of MDA-5 are protective against type I diabetes (24) and there is increasing evidence that enterovirus infection, which is sensed by MDA-5, plays an important role in triggering type I diabetes <ref type="bibr" target="#b43">(42)</ref>.</s><s>A recent paper by Rice et al. found gain-of-function mutations in MDA-5 causing Aicardi-Goutières syndrome and clinical related syndromes.</s><s>In these cases so far unidentified endogenous MDA-5 ligands induce a spontaneous chronic induction of ISGs that are supposed to be causative for the clinical phenotype of a severe inflammatory multi-organ disease <ref type="bibr" target="#b44">(43)</ref>.</s><s>We saw a slight ISG stimulation upon overexpression of MDA5 H843/T946 even in the absence of infection or poly I:C in HEK293 and Huh-7.5 cells.</s><s>Interestingly, Rice et al. argue that baseline ISG-induction due to overexpression of MDA-5 variants in the absence of added ligands is in fact not completely ligand-independent but rather depends on endogenous RNA ligands.</s><s>Their argument being that the additional introduction of mutations disrupting the putative RNA binding site blocks this baseline activation <ref type="bibr" target="#b44">(43)</ref>.</s></p><p><s>It is therefore possible that H843/T946 is an overactive MDA-5 variant that is beneficial for HCV clearance, but might be a risk factor for autoimmune diseases such as diabetes type I.</s><s>We speculate that a strong response to cytoplasmic viral RNA, or baseline activation by endogenous ligands though an advantage in the fight against the persistence of HCV, might trigger autoimmunity by increased bystander activation or induction of apoptosis.</s><s>Further</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>List of Abbreviations</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FRETmelanoma differentiation-associated gene 5 Fig 1 .</head><label>51</label><figDesc><div><p><s>Fig 1.</s><s>The haplotype at rs1990760 and rs3747517 coding for histidine at position 843 and threonine at position 946 in MDA-5 is associated with spontaneous clearance of HCV infection A: The frequency distribution in the combined cohorts 1 and 2 of the four possible MDA-5 haplotypes defined by the two SNPs rs3747517 and rs1990760 is depicted.</s><s>At rs3747517 the minor allele in the European population (T) codes for histidine at position 843 and the major allele (C) for arginine.</s><s>At rs1990760 the minor allele (C) codes for alanine at position 946 and the major allele (T) for threonine.</s><s>The haplotype coding for H843/T946 is suppressed in the group with chronic hepatitis C and associated with clearance of HCV infection.</s><s>B:The frequency of haplotypes encoding H843/T946 was calculated in the group with chronic hepatitis versus the group with spontaneous resolved hepatitis and compared to the distribution of the combined frequency of the three other possible alleles.</s><s>C: The frequency of individuals that are carriers, with either heterozygous or homozygous genotypes, of the H843/T946 haplotype versus individuals that do not carry this haplotype was compared in the groups with chronic hepatitis and spontaneous resolved hepatitis respectively.</s><s>Odds</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. The T/T haplotype at rs1990760 and rs3747517 leading to histidine at position 843 and threonine at position 946 encodes a highly active MDA-5 variantHEK 293 cells were transfected with plasmids coding for the indicated MDA-5 variants (50 ng/well) defined by the four possible amino acid combinations at the amino acid positions 843 and 946 coded by the SNP alleles T/C at rs3747517 and T/C at rs1990760 respectively.</s><s>R843/T946 the most common allele combination (WT) in the European population is highlighted in grey.</s><s>An empty vector and in B) two MDA-5 variants, I923V and E627stop, known to be functionally inactive, were used as negative controls.</s><s>24 hours after transfection cells were stimulated using poly I:C (125 ng/ml) complexed with lipofectamine for</s></p></div></figDesc><graphic coords="15,84.00,62.00,504.00,501.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3.</s><s>The MDA-5 variant with histidine at position 843 and threonine at position 946 has an increased ability to inhibit HCV replication A) Workflow schematic: Huh-7.5 cells were transduced with lentiviral vectors expressing RFP and the indicated ISGs.</s><s>MDA5 R843/T946, the most common allele combination (WT) in the European population, is highlighted in grey.</s><s>Empty vector and two MDA-5 variants, I923V and E627stop, known to be functionally inactive, were used as negative controls.</s><s>A construct coding for IRF1 served as positive control.72 hours after lentiviral transduction, cells were challenged with HCV Jc1 378-1-YPet.</s><s>48 h post infection, we harvested viruscontaining supernatants for TCID 50 determination, and cells for FACS analysis, or mRNA</s></p></div></figDesc><graphic coords="17,146.28,62.00,379.44,503.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 Study population Controls Patients with spontaneously resolved hepatitis C Patients with chronic hepatitis C</head><label>1</label><figDesc></figDesc><table><row><cell cols="2">Number 520</cell><cell>285</cell><cell>509</cell></row><row><cell></cell><cell></cell><cell>Cohort 1: 76</cell><cell>Cohort 1: 199</cell></row><row><cell></cell><cell></cell><cell>Cohort 2: 209</cell><cell>Cohort 2: 310</cell></row><row><cell>Gender</cell><cell>m: 383 (73.7%)</cell><cell>m: 110 (38.6%)</cell><cell>m: 245 (48.1%)</cell></row><row><cell></cell><cell>f: 137 (26.3%)</cell><cell>f: 175 (61.4%)</cell><cell>f: 264 (51.9%)</cell></row><row><cell>Origin</cell><cell cols="2">Germany: 520 (100%) Germany: 253 (88.8%)</cell><cell>Germany: 433 (85.1%)</cell></row><row><cell></cell><cell></cell><cell>Ireland: 28 (9.8%) Southern</cell><cell>Ireland: 48 (9.4%)</cell></row><row><cell></cell><cell></cell><cell>Europe: 2 (0.7%)</cell><cell>Eastern Europe: 16 (3.1%)</cell></row><row><cell></cell><cell></cell><cell>Eastern Europe: 2 (0.7%)</cell><cell>Russia: 10 (2.0%) Southern</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Europe: 2 (0.4%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Allele frequency analysis of non-synonymous, coding SNPs in RIG-I, MDA-5, MAVS and Lgp2 as well as rs12979860 in the IL-28B promoter in individuals with chronic hepatitis C and spontaneously resolved hepatitis C in cohort 1</s></p></div></figDesc><table><row><cell>OR</cell><cell>(95% CI)</cell><cell></cell><cell>0.86</cell><cell>(0.57 -1.29)</cell><cell>1.05</cell><cell>(0.59 -1.89)</cell></row><row><cell cols="2">p-value</cell><cell></cell><cell>0.465</cell><cell></cell><cell>0.881</cell></row><row><cell cols="2">Allele frequency (%)</cell><cell>Control CH SRH</cell><cell>73.4 71.6 68.4</cell><cell>26.6 28.4 31.6</cell><cell>84.2 88.8 88.3</cell><cell>15.8 11.2 11.7</cell></row><row><cell></cell><cell></cell><cell></cell><cell>G</cell><cell>A</cell><cell>A</cell><cell>T</cell></row><row><cell cols="2">SNP ID and alleles</cell><cell></cell><cell>RIG-I: R7C (rs10813831) G/A</cell><cell></cell><cell>D580E (rs17217280) A/T</cell><cell>S183I</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>for allele distribution comparing CH versus SRH; CH, chronic hepatitis.</s><s>SRH, spontaneously resolved hepatitis.</s><s>OR, odds ratio comparing CH versus SRH.</s><s>CI, confidence interval.</s><s>n.d.,</s></p></div></figDesc><table><row><cell>1.32</cell><cell>(0.52 -1.10)</cell><cell>1.67</cell><cell>(1.12 -2.48)</cell><cell>1.19</cell><cell>(1.12 -11.61)</cell><cell>2.78</cell><cell>(0.73 -10.52)</cell><cell>0.70</cell><cell>(0.43 -1.14)</cell><cell>1.44</cell><cell>(0.88 -2.36)</cell><cell>0.87</cell><cell>(0.49 -1.54)</cell><cell>1.31</cell><cell>(0.36 -4.83)</cell><cell>2.4</cell><cell>(1.62 -3.83)</cell></row><row><cell>0.171</cell><cell></cell><cell>0.013</cell><cell></cell><cell>0.876</cell><cell></cell><cell>0.123</cell><cell></cell><cell>0.154</cell><cell></cell><cell>0.149</cell><cell></cell><cell>0.673</cell><cell></cell><cell>0.683</cell><cell></cell><cell>2.5 × 10 −5</cell><cell></cell></row><row><cell>55.3</cell><cell>44.7</cell><cell>60.8</cell><cell>39.2</cell><cell>99.4</cell><cell>0.6</cell><cell>96.6</cell><cell>3.4</cell><cell>80.5</cell><cell>19.5</cell><cell>81.2</cell><cell>18.8</cell><cell>88.2</cell><cell>11.8</cell><cell>98.1</cell><cell>1.9</cell><cell>22.4</cell><cell>77.6</cell></row><row><cell>1</cell><cell>37.9</cell><cell>72.1</cell><cell>27.9</cell><cell>99.2</cell><cell>0.8</cell><cell>98.8</cell><cell>1.2</cell><cell>85.5</cell><cell>14.5</cell><cell>86.1</cell><cell>13.9</cell><cell>86.6</cell><cell>13.4</cell><cell>97.5</cell><cell>2.5</cell><cell>41.8</cell><cell>58.2</cell></row><row><cell></cell><cell></cell><cell>72.4</cell><cell>27.6</cell><cell>98.8</cell><cell>1.2</cell><cell>97.8</cell><cell>2.2</cell><cell>85.1</cell><cell>14.9</cell><cell>84.9</cell><cell>15.1</cell><cell>83.3</cell><cell>16.7</cell><cell>97.8</cell><cell>2.2</cell><cell>n.d.</cell><cell></cell></row><row><cell></cell><cell></cell><cell>R843H (rs3747517) C/T C</cell><cell>T</cell><cell>H460R (rs10930046) T/C T</cell><cell>C</cell><cell>I923V (rs35667974) A/G A</cell><cell>G</cell><cell>Mavs: Q198K (rs7262903) C/A C</cell><cell>A</cell><cell>S409F (rs7269320) C/T C</cell><cell>T</cell><cell>Lgp2: Q425R (rs2074158) A/G A</cell><cell>G</cell><cell>R523Q (rs2074160) G/A G</cell><cell>A</cell><cell>IL-28B: noncoding (rs12979860) T</cell><cell>C</cell><cell>p-value by x 2</cell><cell>not determined.</cell></row></table><note><p><s>test</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 . 1</head><label>31</label><figDesc><div><p><s>Genotype frequencies of MDA-5: R843H (rs3747517), cohort 1 and 2 by x 2 test for genotype distribution.</s><s>CH, chronic hepatitis.</s><s>SRH, spontaneously resolved hepatitis.</s></p></div></figDesc><table><row><cell>Analysed group</cell><cell>CH</cell><cell>SRH</cell><cell>CH</cell><cell>SRH</cell></row><row><cell></cell><cell cols="2">Cohort 1</cell><cell cols="2">Cohort 2</cell></row><row><cell>Genotype</cell><cell cols="2">Frequency (%)</cell><cell cols="2">Frequency (%)</cell></row><row><cell>CC</cell><cell cols="4">105 (52.8%) 26 (35.1%) 166 (53.5%) 107 (51.2%)</cell></row><row><cell>CT</cell><cell>77 (38.7%)</cell><cell cols="2">38 (51.4%) 119 (38.4%)</cell><cell>69 (33%)</cell></row><row><cell>TT</cell><cell>17 (8.5%)</cell><cell>10 (13.5%)</cell><cell>25 (8.1%)</cell><cell>33 (15.8%)</cell></row><row><cell>p-value</cell><cell>0.03</cell><cell></cell><cell>0.02</cell><cell></cell></row><row><cell>p-value</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 . 2</head><label>32</label><figDesc><div><p><s>Allele, genotype and carrier frequencies of MDA-5: R843H (rs3747517), combined cohorts for allele distribution, genotype distribution, C carrier distribution and CC versus TT distribution comparing CH versus SRH.</s><s>CH, chronic hepatitis.</s><s>SRH, spontaneously resolved hepatitis.</s><s>OR, odds ratio.</s><s>CI, confidence interval.</s></p></div></figDesc><table><row><cell>OR</cell><cell>(95% CI)</cell><cell></cell><cell>1.36 (1.10 -1.70)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1.99 (1.27 -3.13)</cell><cell></cell><cell>2.09 (1.30 -3.35)</cell></row><row><cell cols="2">p-value</cell><cell></cell><cell>7 × 10 −3</cell><cell></cell><cell>8 × 10 −3</cell><cell></cell><cell></cell><cell>4 × 10 −3</cell><cell></cell><cell>3 × 10 −3</cell></row><row><cell cols="2">Control CH SRH</cell><cell>Frequency (%)</cell><cell>753 (72.4 %) 738 (72.5 %) 373 (65.9 %)(</cell><cell>287 (27.6 %) 280 (27.5 %) 193 (34.1 %)</cell><cell>271 (52.1 %) 271 (53.2 %) 133 (47.0 %)</cell><cell>211 (40.6 %) 196 (38.5 %) 107 (37.8 %)</cell><cell>38 (7.3 %) 42 (8.3 %) 43 (15.2 %)</cell><cell>482 (92.7 %) 467 (91.7 %) 240 (84.7 %)</cell><cell>38 (7.3 %) 42 (8.3 %) 43 (15.2 %)</cell><cell>271 (52.1 %) 271 (53.2 %) 133 (46.9 %)</cell><cell>38 (7.3 %) 42 (8.3 %) 43 (15.2 %)</cell></row><row><cell cols="2">Analysed group</cell><cell></cell><cell>C</cell><cell>T</cell><cell>CC</cell><cell>CT</cell><cell>TT</cell><cell>CC or CT</cell><cell>TT</cell><cell>CC</cell><cell>TT</cell><cell>p-value by x 2</cell></row></table><note><p><s>test</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Hepatology.Author manuscript; available in PMC 2016 February 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We would like to thank Dr. Müller, Dr. Viazov, Dr. Roggendorf and the other members and organizers of the German Kompetenznetz Hepatitis for access to their sample collection and databases and all involved patients and their physicians for enabling this study.</s><s>We are grateful to Paul Bieniasz, The Rockefeller University, for providing us with the SCRPSY lentivirus vector.</s><s>We thank Dr. E. Albert for carefully reading the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Grant support</head><p><s>The study was supported by DFG RO 2525/3-1 and RO 2525</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>studies will be needed to see if the strong effect of the H843/T946 MDA-5 variant on HCV clearance can be generalized to other viral infections sensed by MDA-5, and is conversely associated with increased risk to autoimmune diseases beyond type I diabetes as suggested by recent studies <ref type="bibr" target="#b45">(44)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Romero-Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eslam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ruiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maraver</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Liver Int</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="443" to="460" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21382156</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Host genetic basis for hepatitis C virus clearance: a role for blood collection centers</title>
		<author>
			<persName><forename type="first">S</forename><surname>Selvarajah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Tobler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Busch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Hematol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="550" to="557" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20729732</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fellay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Shianna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Urban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Heinzen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">461</biblScope>
			<biblScope unit="page" from="399" to="401" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19684573</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Suppiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moldovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ahlenstiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weltman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Abate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bassendine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1100" to="1104" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19749758</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sugiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kurosaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsuura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sakamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakagawa</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C</title>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1105" to="1109" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19749757</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Genetic variation in IL28B and spontaneous clearance of hepatitis C virus</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Thio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>O'huigin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kidd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">461</biblScope>
			<biblScope unit="page" from="798" to="801" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19759533</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Interferon-stimulated genes and their role in controlling hepatitis C virus</title>
		<author>
			<persName><forename type="first">P</forename><surname>Metz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bartenschlager</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1331" to="1341" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23933585</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Interferon-stimulated genes and their antiviral effector functions</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Schoggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Virol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="519" to="525" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22328912</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Pattern recognition receptors and inflammation</title>
		<author>
			<persName><forename type="first">O</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="805" to="820" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20303872</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">5′-Triphosphate RNA is the ligand for RIG-I</title>
		<author>
			<persName><forename type="first">V</forename><surname>Hornung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ellegast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Brzozka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Poeck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="page" from="994" to="997" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 17038590</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Activation of MDA5 requires higher-order RNA structures generated during virus infection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pichlmair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rehwinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="10761" to="10769" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19656871</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schwerd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Hellmuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="12067" to="12072" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19574455</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Immune signaling by RIG-I-like receptors</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gale</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="680" to="692" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21616437</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Pattern recognition of viral nucleic acids by RIG-I-like helicases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Endres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rothenfusser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="5" to="12" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 20820752</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Regulation of hepatic innate immunity by hepatitis C virus</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Horner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gale</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="879" to="888" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23836238</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus</title>
		<author>
			<persName><forename type="first">E</forename><surname>Meylan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moradpour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Binder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bartenschlager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tschopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">437</biblScope>
			<biblScope unit="page" from="1167" to="1172" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16177806</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A diverse range of gene products are effectors of the type I interferon antiviral response</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Schoggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Panis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bieniasz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">472</biblScope>
			<biblScope unit="page" from="481" to="485" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21478870</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sumpter</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Foy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoneyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Lemon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="2689" to="2699" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15708988</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kenny-Walsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page" from="1228" to="1233" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>PubMed: 10210705</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Horwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dorner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Friling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Donovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Loureiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Oh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">439</biblScope>
			<biblScope unit="page" from="23" to="33" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23485372</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Complete replication of hepatitis C virus in cell culture</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Lindenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Syder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wolk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Tellinghuisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maruyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="623" to="626" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15947137</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Podolsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bode</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="358" to="365" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 18927125</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferoninduced helicase (IFIH1) region</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Smyth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Field</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Burren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Smink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guja</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="617" to="619" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16699517</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nejentsev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Riches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Egholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Todd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="page" from="387" to="389" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19264985</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shigemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kageyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hirai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoneyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="page" from="13348" to="13354" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19324880</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Seth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pineda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="17717" to="17722" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16301520</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Fredericksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fornek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Katze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gale</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="609" to="616" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17977974</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A genome-wide genetic screen for host factors required for hepatitis C virus propagation</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Brass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Xavier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Elledge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="16410" to="16415" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19717417</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection</title>
		<author>
			<persName><forename type="first">B</forename><surname>Israelow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Narbus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sourisseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Evans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Andrus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marukian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Catanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Sheahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Schoggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Barry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1901" to="1912" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22144107</note>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Motz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Schuhmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kirchhofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Conzelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Hopfner</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling</title>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="690" to="693" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23328395</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gitlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Barchet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gilfillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Beutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Flavell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Diamond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="8459" to="8464" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16714379</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Lengthdependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mikamo-Satoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hirai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kawai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsushita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hiiragi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="page" from="1601" to="1610" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18591409</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses</title>
		<author>
			<persName><forename type="first">K</forename><surname>Triantafilou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vakakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Richer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Triantafilou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Sci</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="4761" to="4769" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22797917</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Study of transcriptional effects in Cis at the IFIH1 locus</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zouk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marchand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Polychronakos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e11564</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20644636</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kowalinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lunardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mccarthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Louber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brunel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grigorov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gerlier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="423" to="435" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22000019</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Structural insights into RNA recognition by RIG-I</title>
		<author>
			<persName><forename type="first">D</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kohlway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Lindenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Pyle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="409" to="422" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22000018</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Structural basis of RNA recognition and activation by innate immune receptor RIG-I</title>
		<author>
			<persName><forename type="first">F</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ramanathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Q</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gale</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marcotrigiano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">479</biblScope>
			<biblScope unit="page" from="423" to="427" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21947008</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5</title>
		<author>
			<persName><forename type="first">B</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Peisley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="276" to="289" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23273991</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition</title>
		<author>
			<persName><forename type="first">A</forename><surname>Peisley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Orme-Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="21010" to="21015" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22160685</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">MDA5 assembles into a polar helical filament on dsRNA</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Berke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Modis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Egelman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="18437" to="18441" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23090998</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Enteroviruses in the pathogenesis of type 1 diabetes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tauriainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Oikarinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oikarinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hyoty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Immunopathol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="45" to="55" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 20424841</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Toro Duany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jenkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Forte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Ariaudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bader-Meunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="503" to="509" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24686847</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">X</forename><surname>Leng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmunity</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="455" to="462" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23734776</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
